Syllabus: GS2/ Health
Context
- The need to expand PMBJP has gained importance in reducing high out-of-pocket expenditure on medicines and improving access to affordable healthcare in India.
About Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana
- The scheme was first launched in 2008 as the Jan Aushadhi Scheme. In 2015 it was restructured and later renamed Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana in 2016.
- Nodal Ministry: Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers.
- Implementing Agency: Pharmaceuticals and Medical Devices Bureau of India (PMBI).
- Objective: To provide quality generic medicines at affordable prices through dedicated outlets called Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs).
- Generic medicines: Medicines containing the same active pharmaceutical ingredients (APIs), strength and dosage as their branded equivalents, generally sold at lower prices.
- Key Achievements:
- Expansion of outlets: 20,547 Jan Aushadhi Kendras were operational by July 2026, against the target of 25,000 by March 2027.
- Wider medicine basket: Provides 2,110 medicines and 315 surgical items.
- The medicines under PMBJP are made available at rates that are about 50% to 80% cheaper than those of branded medicines.
- Household savings: Estimated savings of approximately ₹9,000 crore during 2025–26 and ₹45,000 crore over 12 years.
Other Initiatives under the Scheme
- The Janaushadhi Suvidha Oxo-biodegradable Sanitary Napkins is one key initiative, introduced in 2019, to enhance affordable access to menstrual hygiene products for women across India.
- The “Jan Aushadhi Sugam” mobile application was launched in 2019 to strengthen accessibility, transparency, and user convenience. Key features include:
- Geolocation-enabled identification of the nearest JAK through Google Maps integration.
- Search functionality for generic medicines along with real-time availability status, and
- Comparative analysis of maximum retail prices (MRPs) between Jan Aushadhi generics and branded alternatives, highlighting potential cost savings.
Institutional and Regulatory Requirements for Establishing a PMBJK Outlet
- Individuals holding a D. Pharma or B. Pharma qualification, as well as individuals/organizations employing a qualified pharmacist, are eligible to establish a JAKs.
- The principal eligibility criteria are as follows:
- Minimum space: 120 square feet.
- Pharmacist registration: The pharmacist must be registered with the State Pharmacy Council in the state where they practise.
Significance of the Scheme
- Reduces out-of-pocket expenditure (OOPE): Makes essential medicines affordable, particularly for low-income households and patients requiring long-term medication.
- Promotes universal health coverage: Improves access to affordable medicines, an important component of the right to health.
- Creates demand for generic medicines and supports India’s position as a major global supplier of affordable medicines.
Challenges in Effective Implementation
- Limited geographical reach: Despite the expansion of Kendras, their number remains small compared to India’s extensive network of private pharmacies.
- Low public awareness: Many consumers are unaware of the scheme, the medicines available and the potential cost savings.
- Quality-related concerns: Perceptions regarding the quality and efficacy of generic medicines affect public confidence and doctors’ willingness to prescribe them.
- Limited doctors’ participation: Preference for branded medicines and concerns regarding accountability and quality restrict generic prescriptions.
Way Ahead
- Conduct national surveys to identify gaps in awareness, availability and consumer satisfaction.
- Ensure independent quality testing and transparent publication of results.
- Introduce digital stock tracking to prevent medicine shortages.
- Build doctors’ confidence in generic medicines through quality assurance.
Source: TH
Previous article
Microfinance Sector in India
Next article
AI, Productivity & Global Growth